Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

443 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Complex karyotype in patients with mantle cell lymphoma predicts inferior survival and poor response to intensive induction therapy.
Greenwell IB, Staton AD, Lee MJ, Switchenko JM, Saxe DF, Maly JJ, Blum KA, Grover NS, Mathews SP, Gordon MJ, Danilov AV, Epperla N, Fenske TS, Hamadani M, Park SI, Flowers CR, Cohen JB. Greenwell IB, et al. Among authors: flowers cr. Cancer. 2018 Jun 1;124(11):2306-2315. doi: 10.1002/cncr.31328. Epub 2018 Mar 26. Cancer. 2018. PMID: 29579328 Free PMC article.
Maintenance therapy in lymphoma.
Mihelic R, Kaufman J, Lonial S, Flowers C. Mihelic R, et al. Clin Lymphoma Myeloma. 2007 Sep;7(8):507-13. doi: 10.3816/clm.2007.n.034. Clin Lymphoma Myeloma. 2007. PMID: 18021467 Review.
A phase I/II trial combining high-dose melphalan and autologous transplant with bortezomib for multiple myeloma: a dose- and schedule-finding study.
Lonial S, Kaufman J, Tighiouart M, Nooka A, Langston AA, Heffner LT, Torre C, McMillan S, Renfroe H, Harvey RD, Lechowicz MJ, Khoury HJ, Flowers CR, Waller EK. Lonial S, et al. Among authors: flowers cr. Clin Cancer Res. 2010 Oct 15;16(20):5079-86. doi: 10.1158/1078-0432.CCR-10-1662. Epub 2010 Aug 25. Clin Cancer Res. 2010. PMID: 20739431 Clinical Trial.
Novel agents for diffuse large B-cell lymphoma.
Sinha R, DeJoubner N, Flowers C. Sinha R, et al. Expert Opin Investig Drugs. 2011 May;20(5):669-80. doi: 10.1517/13543784.2011.565745. Epub 2011 Mar 28. Expert Opin Investig Drugs. 2011. PMID: 21443388 Review.
Pharmacokinetic-directed high-dose busulfan combined with cyclophosphamide and etoposide results in predictable drug levels and durable long-term survival in lymphoma patients undergoing autologous stem cell transplantation.
Zhang H, Graiser M, Hutcherson DA, Dada MO, McMillan S, Ali Z, Flowers CR, Waller EK. Zhang H, et al. Among authors: flowers cr. Biol Blood Marrow Transplant. 2012 Aug;18(8):1287-94. doi: 10.1016/j.bbmt.2012.02.006. Epub 2012 Feb 25. Biol Blood Marrow Transplant. 2012. PMID: 22370160 Free article.
A phase 1 dose escalation study of bortezomib combined with rituximab, cyclophosphamide, doxorubicin, modified vincristine, and prednisone for untreated follicular lymphoma and other low-grade B-cell lymphomas.
Sinha R, Kaufman JL, Khoury HJ Jr, King N, Shenoy PJ, Lewis C, Bumpers K, Hutchison-Rzepka A, Tighiouart M, Heffner LT, Lechowicz MJ, Lonial S, Flowers CR. Sinha R, et al. Among authors: flowers cr. Cancer. 2012 Jul 15;118(14):3538-48. doi: 10.1002/cncr.26660. Epub 2012 Jan 3. Cancer. 2012. PMID: 22535574 Free article. Clinical Trial.
443 results